New Psychedelic Research Nonprofit Teams with Johns Hopkins University for Real-World Study on Use of Psilocybin MushrooPharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the NetherlandsCybin Corp. Is A Multi-Faceted Life Sciences Company Investors Should Have On Their RadarMindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic WellneNovamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.Psychedelic Assisted Therapy Is Becoming A Very Real Alternative Method To Treat Mental IllnessNuminus and Together We Can Partner to Support Addiction Recovery and Mental WellnessMydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMOGood2Go Corp. and Magical Brands Inc. Announce Update to Proposed Qualifying TransactionThe Psychedelic Legalization Movement Is In Full BloomNuminus Announces Short Form Prospectus Offering of Units for Gross Proceeds of up to $4.05 MillionNuminus Wellness Is Putting Key Pieces In Place To Drive Cutting Edge Research In The Field Of PsychedelicsMagicMed Industries Inc. Announces Brokered Private Placement with Mackie Research Capital CorporationCybin Corp. Announces Proposed Management Team and Board of Directors of the Resulting IssuerMydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading EuropeanWill Psychedelics Take The Same Trip Down The Road To Legalization As The Cannabis Industry?PharmaDrug Inc. Proposes a Strategic Mutual Investment with Red Light Holland Corp.Pure Extracts Has Significant Leverage To Both The Cannabis and Psychedelic SectorsRritual Mushrooms Is Here to Enhance You Daily “Ritual”MagicMed Industries Files First Psychedelic Derivative Patent
Back

The Psychedelic Legalization Movement Is In Full Bloom

Jul 24, 2020 • 7:25 AM EDT
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

During the last year, we have seen an increase in the number of governments that are easing regulations against the psychedelic market. Most notably, major cities in California, Colorado and Oregon, have decriminalized psilocybin and this is a development that our readers need to be aware of.

The easing of regulations in these markets have brought up the discussion about the legalization of psychedelics and some analysts expect to see the industry follow the path of the cannabis market.

2020 has been a banner year for the psychedelic market as leading psychedelic companies continue to advance therapies through the US Food and Drug Administration (FDA) clinical trial process. We believe that the successful completion of FDA clinical trials would be the most significant catalyst for the sector, and we are favorable on the potential that is associated with this aspect of the industry.

Early reports indicate that psychedelic therapies have the potential to treat a variety of debilitating mental illnesses and we are favorable on this. Many of the indications that these therapies are focused on do not have a proven treatment and have a large total addressable market (TAM).

The initial data from clinical trials show that psilocybin mushrooms can effectively treat obsessive-compulsive disorder (OCD), post-traumatic-stress-disorder (PTSD), opioid addiction, alcoholism, eating disorders, depression, anxiety, and possibly even weight loss. We are favorable on the potential that is associated with the markets for psychedelic therapies and find this to be an attractive aspect of the market landscape.

We believe that the psychedelic sector is not even in the early innings of a secular growth cycle and are favorable on the tailwinds that are benefiting the industry. The continued easing of regulations in North America are benefiting the companies that are focused on this emerging market and are expecting further positive developments on this side of the industry.

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link